Sierra Leone's mpox cases fuel African outbreak, says health body
Sierra Leone accounted for half of Africa's confirmed mpox cases this week, the continent's main health body said on Thursday, adding that the West African country was fuelling the outbreak.
Mpox is a viral infection that spreads through close contact and typically causes flu-like symptoms and pus-filled lesions. It is usually mild, but can be lethal.
It remains a public health emergency due to the continuing rise in the number of cases and the geographic spread of the outbreak, according to the WHO, which first declared the emergency in August last year.
The Africa Centres for Disease Control and Prevention (Africa CDC) said Sierra Leone reported 384 confirmed cases in a week, representing 50.7% of all the continent's cases.
Sierra Leone, which declared mpox a public health emergency in January, has seen a 63% jump in confirmed cases in just one week, Africa CDC official Ngashi Ngongo said in an online briefing.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TimesLIVE
17 hours ago
- TimesLIVE
Health teams are monitoring Covid's ‘Nimbus' variant
South Africa is closely monitoring the emergence of a new Covid-19 variant, known as Nimbus or NB.1.8.1, the national health department says. This comes after the National Institute for Communicable Diseases (NICD) said NB.1.8.1 has an Omicron-descendent lineage and was first detected in January in Asia, and was designated a variant under monitoring by the World Health Organisation (WHO) on May 23. The NB.1.8.1 variant is increasing in prevalence globally, from 2.5% of sequences submitted to the Global Initiative on Sharing All Influenza Data between March 31 to April 6 to 10.7% in epidemiological week April 21 to 27. By May 18, it had been detected in 22 countries, and has been associated with an increase in SARS-CoV-2 infections in parts of Asia, the NICD said. Covid vaccines are expected to provide protection against severe illness due to NB.1.8.1 infections and the WHO considers the public health risk of NB.1.8.1 to be low. As of June 10, the NB.1.8.1 variant has not been detected in SA, the NICD said, with the caveat that SARS-CoV-2 testing throughout the country is limited and few specimens are being submitted for sequencing. However, data from the NICD's respiratory illness syndromic surveillance programmes, which operate in selected public and private hospitals and outpatient facilities, show the number of SARS-CoV-2 infections is low. The country is seeing an increase in influenza cases due to the winter season. The NICD advised those who are unwell with respiratory symptoms to practice regular hand washing, cover coughs and sneezes and avoid contact with people who may be at high risk of severe respiratory illness.
Eyewitness News
17 hours ago
- Eyewitness News
Health minister urges continuous safety and hygiene measures as new Covid variant is detected in Asia
CAPE TOWN - Health Minister Aaron Motsoaledi is urging the public to continue regular hygiene and safety measures amid a new Covid variant detected in Asia. Speaking at the 4th G20 health working group meeting held in Johannesburg on Tuesday the minister detailed that the new Covid variant has only been detected in parts of Asia. The National Institute for Communicable Diseases (NICD) said there are no signs of an increase in severity or different symptoms. Motsoaledi said that they will continue to monitor the variant closely and report any significant changes. "At this stage, no specific new public health actions are required from the public. But we continue to advocate for maintaining good hygiene practices such as hand washing, covering coughs and staying home when unwell. These simple measures are effective in reducing the spread of all respiratory illnesses,' said Motsoaledi. Meanwhile, the NICD has confirmed that the new covid variant hasn't been detected in South Africa. The variant was first detected in January this year under the name nb.1.8.1. The NICD said while there are no recorded cases in the country testing of the variant is limited and few specimens are being submitted for sequencing. "The WHO has designated this variant under monitoring due to its growing presence. I wish to reassure the esteemed gathering that South Africa has robust surveillance systems in place. Our National Institute for Communicable Diseases known as NICD manages a comprehensive sentinel surveillance programme that systematically tests for key respiratory viruses including covid-19 influenza and the respiratory syncytial virus," said Motsoaledi.
TimesLIVE
a day ago
- TimesLIVE
Groundbreaking study finds new genes in black women causing breast cancer
Black South African women have been found to have two new genes that make them susceptible to breast cancer. Research done by the Sydney Brenner Institute for Molecular Bioscience (SBIMB) at the Witwatersrand University found genetic factors that contribute to about 30% of breast cancer (BC) cases in South Africa. 'These genes have not been associated with the disease before, which is an important advance in understanding breast cancer risk and biology in women of African ancestry,' said Dr Mahtaab Hayat, a lead author of the study. The two new genetic variants were identified in black South African women with breast cancer enrolled in the Johannesburg Cancer Study, compared to women without cancer in the Africa Wits-INDEPTH Partnership for Genomic Research (AWI-Gen) study. Breast cancer is the second-most common cancer in South Africa and the most common cancer in women globally, with genetic factors contributing to about 30% of cases. 'Our study makes a compelling case for investing in genomic research rooted in African contexts,' said Hayat. All participants were from the Soweto region, with 2,485 population cases and 1,101 control cases. The South African BC cases and controls were well-matched and clustered, while the non-South African samples and West African populations were distinct from South African populations. The Genome-Wide Association study (Gwas), which is the first to focus on black women on the continent, was published in the journal Nature Communications. It brings to the fore the importance of deepening knowledge about the genetic basis of the disease. In the past, most breast cancer genetics research has focused on European and Asian populations, with studies of African ancestry limited primarily to African-American women, who largely descend from West African populations. A tool that estimates lifetime cancer risk based on DNA, the polygenic risk score (PRS), performed poorly in distinguishing South African women with breast cancer from those without. Dr Jean-Tristan Brandenburg, also in the SBIMB and a lead author, said this was a result of the mechanism not being tailored for the black population. 'This is because most PRSs were developed in European populations, and their inaccuracy in African populations highlights the urgent need for ancestry-specific tools in cancer risk prediction,' Brandenburg said. African populations have more genetic variation than any other population in the world, but they have been significantly underrepresented in genomic research. This means that the global understanding of disease risk and the tools and treatment developed from it are limited. 'The study reveals that more people can benefit from genetic discoveries. It proves that new risk factors are still out there, waiting to be found,' says Hayat.
